Collective Health valuation, funding and investors
Collective Health works in integrated health benefits solutions, based in San Francisco, United States. Founded in 2013, it has about 791 employees.
- Last round
- Series F · $280M · May 2021
- Valuation at last round
- $1.50B
- Headcount
- 791 · up
- Grade
- D
- Founded
- 2013
Collective Health valuation today
VCMC values Collective Health at $1.8B today, with a range of $277M to $2.2B and a grade of D. The valuation starts from its last funding round, a Series F round in May 2021.
Valuation by date (172 rows)
Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.
| Date | Valuation | Range | Predicted in 1 yr | Phase | Headcount | Trend | Grade | Winding-down probability |
|---|---|---|---|---|---|---|---|---|
| 1 Jan 2013 | $6.07M | $2.21M – $16.7M | $6.36M (+5%) | before first round | – | unknown | D | 0% |
| 1 Feb 2013 | $6.09M | $2.22M – $16.7M | $6.39M (+5%) | before first round | – | unknown | D | 0% |
| 1 Mar 2013 | $6.12M | $2.23M – $16.8M | $6.41M (+5%) | before first round | – | unknown | D | 0% |
| 1 Apr 2013 | $6.14M | $2.24M – $16.9M | $6.43M (+5%) | before first round | – | unknown | D | 0% |
| 1 May 2013 | $6.16M | $2.24M – $16.9M | $6.46M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jun 2013 | $6.19M | $2.25M – $17.0M | $6.48M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jul 2013 | $6.21M | $2.26M – $17.1M | $6.51M (+5%) | before first round | – | unknown | D | 0% |
| 1 Aug 2013 | $6.24M | $2.27M – $17.1M | $6.54M (+5%) | before first round | – | unknown | D | 0% |
| 1 Sep 2013 | $6.26M | $2.28M – $17.2M | $6.56M (+5%) | before first round | – | unknown | D | 0% |
| 1 Oct 2013 | $6.29M | $2.29M – $17.3M | $6.59M (+5%) | before first round | – | unknown | D | 0% |
| 1 Nov 2013 | $6.31M | $2.30M – $17.3M | $6.61M (+5%) | before first round | – | unknown | D | 0% |
| 1 Dec 2013 | $6.33M | $2.31M – $17.4M | $6.64M (+5%) | before first round | – | unknown | D | 0% |
| 1 Jan 2014 | $33.3M | $21.9M – $91.3M | $60.0M (+80%) | after a round | – | unknown | C | 0% |
| 2 Jan 2014 | $33.4M | $21.9M – $91.3M | $60.0M (+80%) | after a round | – | unknown | C | 0% |
| 1 Feb 2014 | $35.0M | $21.9M – $91.3M | $60.0M (+71%) | after a round | – | unknown | C | 0% |
| 1 Mar 2014 | $36.7M | $21.9M – $91.3M | $60.0M (+64%) | after a round | – | unknown | C | 0% |
| 1 Apr 2014 | $38.5M | $21.9M – $91.3M | $60.0M (+56%) | after a round | – | unknown | C | 0% |
| 1 May 2014 | $40.4M | $21.9M – $91.3M | $60.0M (+48%) | after a round | – | unknown | C | 0% |
| 1 Jun 2014 | $42.5M | $21.9M – $91.3M | $60.0M (+41%) | after a round | – | unknown | C | 0% |
| 1 Jul 2014 | $44.6M | $21.9M – $91.3M | $60.0M (+35%) | after a round | – | unknown | C | 0% |
| 1 Aug 2014 | $46.9M | $21.9M – $91.3M | $60.0M (+28%) | after a round | – | unknown | C | 0% |
| 1 Sep 2014 | $49.3M | $21.9M – $91.3M | $60.0M (+22%) | after a round | – | unknown | C | 0% |
| 1 Oct 2014 | $51.7M | $21.9M – $91.3M | $60.0M (+16%) | after a round | – | unknown | C | 0% |
| 1 Nov 2014 | $54.4M | $21.9M – $91.3M | $60.0M (+10%) | after a round | – | unknown | C | 0% |
| 1 Dec 2014 | $57.1M | $21.9M – $91.3M | $60.0M (+5%) | after a round | – | unknown | C | 0% |
| 1 Jan 2015 | $60.0M | $21.9M – $91.3M | $60.0M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2015 | $60.0M | $20.8M – $91.3M | $60.0M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2015 | $60.0M | $19.9M – $91.3M | $60.0M (0%) | after a round | – | unknown | C | 0% |
| 19 Mar 2015 | $153M | $108M – $326M | $230M (+50%) | after a round | – | unknown | B | 0% |
| 1 Apr 2015 | $156M | $108M – $326M | $230M (+48%) | after a round | – | unknown | B | 0% |
| 1 May 2015 | $161M | $108M – $326M | $230M (+43%) | after a round | – | unknown | B | 0% |
| 1 Jun 2015 | $167M | $108M – $326M | $230M (+38%) | after a round | – | unknown | B | 0% |
| 1 Jul 2015 | $172M | $108M – $326M | $230M (+33%) | after a round | – | unknown | B | 0% |
| 1 Aug 2015 | $178M | $108M – $326M | $230M (+29%) | after a round | – | unknown | B | 0% |
| 1 Sep 2015 | $184M | $108M – $326M | $230M (+25%) | after a round | – | unknown | B | 0% |
| 1 Oct 2015 | $191M | $108M – $326M | $230M (+21%) | after a round | – | unknown | B | 0% |
| 21 Oct 2015 | $462M | $325M – $851M | $600M (+30%) | after a round | – | unknown | B | 0% |
| 1 Nov 2015 | $465M | $325M – $851M | $600M (+29%) | after a round | – | unknown | B | 0% |
| 1 Dec 2015 | $476M | $325M – $851M | $600M (+26%) | after a round | – | unknown | B | 0% |
| 1 Jan 2016 | $486M | $325M – $851M | $600M (+23%) | after a round | – | unknown | B | 0% |
| 1 Feb 2016 | $497M | $325M – $851M | $600M (+21%) | after a round | – | unknown | B | 0% |
| 1 Mar 2016 | $508M | $325M – $851M | $600M (+18%) | after a round | – | unknown | B | 0% |
| 1 Apr 2016 | $519M | $325M – $851M | $600M (+16%) | after a round | – | unknown | B | 0% |
| 1 May 2016 | $530M | $325M – $851M | $600M (+13%) | after a round | – | unknown | B | 0% |
| 1 Jun 2016 | $542M | $325M – $851M | $600M (+11%) | after a round | – | unknown | B | 0% |
| 1 Jul 2016 | $554M | $325M – $851M | $600M (+8%) | after a round | – | unknown | B | 0% |
| 1 Aug 2016 | $567M | $325M – $851M | $600M (+6%) | after a round | – | unknown | B | 0% |
| 1 Sep 2016 | $579M | $325M – $851M | $600M (+4%) | after a round | – | unknown | B | 0% |
| 1 Oct 2016 | $592M | $325M – $851M | $600M (+1%) | after a round | – | unknown | B | 0% |
| 1 Nov 2016 | $600M | $319M – $851M | $600M (0%) | after a round | – | unknown | B | 0% |
| 1 Dec 2016 | $600M | $305M – $851M | $600M (0%) | after a round | – | unknown | B | 0% |
| 1 Jan 2017 | $600M | $291M – $851M | $600M (0%) | after a round | – | unknown | B | 0% |
| 1 Feb 2017 | $600M | $278M – $851M | $600M (0%) | after a round | – | unknown | B | 0% |
| 1 Mar 2017 | $600M | $267M – $851M | $600M (0%) | after a round | – | unknown | B | 0% |
| 1 Apr 2017 | $600M | $255M – $851M | $600M (0%) | after a round | – | unknown | C | 0% |
| 1 May 2017 | $600M | $243M – $851M | $600M (0%) | after a round | – | unknown | C | 0% |
| 1 Jun 2017 | $600M | $232M – $851M | $600M (0%) | after a round | – | unknown | C | 0% |
| 1 Jul 2017 | $600M | $222M – $851M | $600M (0%) | after a round | – | unknown | C | 0% |
| 1 Aug 2017 | $600M | $212M – $851M | $600M (0%) | after a round | – | unknown | C | 0% |
| 1 Sep 2017 | $600M | $202M – $851M | $600M (0%) | after a round | – | unknown | C | 0% |
| 1 Oct 2017 | $600M | $194M – $851M | $600M (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2017 | $600M | $175M – $851M | $600M (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2017 | $600M | $166M – $851M | $600M (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2018 | $600M | $158M – $851M | $600M (0%) | after a round | – | unknown | C | 0% |
| 1 Feb 2018 | $600M | $150M – $851M | $600M (0%) | after a round | – | unknown | C | 0% |
| 1 Mar 2018 | $600M | $144M – $851M | $600M (0%) | after a round | – | unknown | C | 0% |
| 1 Apr 2018 | $600M | $136M – $851M | $600M (0%) | after a round | – | unknown | C | 0% |
| 1 May 2018 | $600M | $130M – $851M | $600M (0%) | after a round | – | unknown | C | 0% |
| 1 Jun 2018 | $600M | $123M – $851M | $600M (0%) | after a round | – | unknown | C | 0% |
| 1 Jul 2018 | $600M | $117M – $851M | $600M (0%) | after a round | – | unknown | C | 0% |
| 1 Aug 2018 | $600M | $112M – $851M | $600M (0%) | after a round | – | unknown | D | 0% |
| 1 Sep 2018 | $600M | $106M – $851M | $600M (0%) | after a round | – | unknown | D | 0% |
| 1 Oct 2018 | $600M | $101M – $851M | $600M (0%) | after a round | – | unknown | D | 0% |
| 1 Nov 2018 | $600M | $96.0M – $851M | $600M (0%) | after a round | – | unknown | D | 0% |
| 1 Dec 2018 | $600M | $91.4M – $851M | $600M (0%) | after a round | – | unknown | D | 0% |
| 1 Jan 2019 | $600M | $86.8M – $851M | $600M (0%) | after a round | – | unknown | D | 0% |
| 1 Feb 2019 | $600M | $82.5M – $851M | $600M (0%) | after a round | – | unknown | D | 0% |
| 1 Mar 2019 | $600M | $78.8M – $851M | $600M (0%) | after a round | – | unknown | D | 0% |
| 1 Apr 2019 | $600M | $74.9M – $851M | $600M (0%) | after a round | – | unknown | D | 0% |
| 1 May 2019 | $600M | $71.3M – $851M | $600M (0%) | after a round | – | unknown | D | 0% |
| 1 Jun 2019 | $600M | $67.8M – $851M | $600M (0%) | after a round | – | unknown | D | 0% |
| 18 Jun 2019 | $2.6B | $1.7B – $5.1B | $3.3B (+30%) | after a round | – | unknown | B | 0% |
| 1 Jul 2019 | $2.6B | $1.7B – $5.1B | $3.3B (+29%) | after a round | – | unknown | B | 0% |
| 1 Aug 2019 | $2.6B | $1.7B – $5.1B | $3.3B (+26%) | after a round | – | unknown | B | 0% |
| 1 Sep 2019 | $2.7B | $1.7B – $5.1B | $3.3B (+23%) | after a round | – | unknown | B | 0% |
| 1 Oct 2019 | $2.8B | $1.7B – $5.1B | $3.3B (+20%) | after a round | – | unknown | B | 0% |
| 1 Nov 2019 | $2.8B | $1.7B – $5.1B | $3.3B (+18%) | after a round | – | unknown | B | 0% |
| 1 Dec 2019 | $2.9B | $1.7B – $5.1B | $3.3B (+15%) | after a round | – | unknown | B | 0% |
| 1 Jan 2020 | $3.0B | $1.7B – $5.1B | $3.3B (+13%) | after a round | – | unknown | B | 0% |
| 1 Feb 2020 | $3.0B | $1.7B – $5.1B | $3.3B (+10%) | after a round | – | unknown | B | 0% |
| 1 Mar 2020 | $3.1B | $1.7B – $5.1B | $3.3B (+8%) | after a round | – | unknown | B | 0% |
| 1 Apr 2020 | $3.2B | $1.7B – $5.1B | $3.3B (+6%) | after a round | – | unknown | B | 0% |
| 1 May 2020 | $3.2B | $1.7B – $5.1B | $3.3B (+3%) | after a round | – | unknown | B | 0% |
| 1 Jun 2020 | $3.3B | $1.7B – $5.1B | $3.3B (+1%) | after a round | – | unknown | B | 0% |
| 1 Jul 2020 | $3.3B | $1.6B – $5.1B | $3.3B (0%) | after a round | – | unknown | B | 0% |
| 1 Aug 2020 | $3.3B | $1.6B – $5.1B | $3.3B (0%) | after a round | – | unknown | B | 0% |
| 1 Sep 2020 | $3.3B | $1.5B – $5.1B | $3.3B (0%) | after a round | – | unknown | C | 0% |
| 1 Oct 2020 | $3.3B | $1.4B – $5.1B | $3.3B (0%) | after a round | – | unknown | C | 0% |
| 1 Nov 2020 | $3.3B | $1.4B – $5.1B | $3.3B (0%) | after a round | – | unknown | C | 0% |
| 1 Dec 2020 | $3.3B | $1.3B – $5.1B | $3.3B (0%) | after a round | – | unknown | C | 0% |
| 1 Jan 2021 | $3.3B | $1.3B – $5.1B | $3.3B (0%) | after a round | 440 | unknown | C | 0% |
| 1 Feb 2021 | $3.3B | $1.2B – $5.1B | $3.3B (0%) | after a round | 440 | unknown | C | 0% |
| 1 Mar 2021 | $3.3B | $1.1B – $5.1B | $3.3B (0%) | after a round | 440 | unknown | C | 0% |
| 1 Apr 2021 | $3.3B | $1.1B – $5.1B | $3.3B (0%) | after a round | 440 | flat | C | 0% |
| 1 May 2021 | $3.3B | $1.0B – $5.1B | $3.3B (0%) | after a round | 440 | flat | C | 0% |
| 5 May 2021 | $1.5B | $1.3B – $2.2B | $2.0B (+30%) | after a round | 440 | flat | A | 0% |
| 1 Jun 2021 | $1.5B | $1.3B – $2.2B | $2.0B (+27%) | after a round | 440 | flat | A | 0% |
| 1 Jul 2021 | $1.6B | $1.3B – $2.2B | $2.0B (+25%) | after a round | 440 | flat | A | 0% |
| 1 Aug 2021 | $1.6B | $1.3B – $2.2B | $2.0B (+22%) | after a round | 440 | flat | A | 0% |
| 1 Sep 2021 | $1.6B | $1.3B – $2.2B | $2.0B (+19%) | after a round | 440 | flat | A | 0% |
| 1 Oct 2021 | $1.7B | $1.3B – $2.2B | $2.0B (+17%) | after a round | 440 | flat | A | 0% |
| 1 Nov 2021 | $1.7B | $1.3B – $2.2B | $2.0B (+14%) | after a round | 440 | flat | A | 0% |
| 1 Dec 2021 | $1.7B | $1.3B – $2.2B | $2.0B (+12%) | after a round | 440 | flat | A | 0% |
| 1 Jan 2022 | $1.8B | $1.3B – $2.2B | $2.0B (+9%) | after a round | 440 | flat | A | 0% |
| 1 Feb 2022 | $1.8B | $1.3B – $2.2B | $2.0B (+7%) | after a round | 440 | flat | A | 0% |
| 1 Mar 2022 | $1.9B | $1.3B – $2.2B | $2.0B (+5%) | after a round | 440 | flat | A | 0% |
| 1 Apr 2022 | $2.0B | $1.3B – $2.4B | $2.1B (+3%) | after a round | 560 | up | A | 0% |
| 1 May 2022 | $2.1B | $1.3B – $2.4B | $2.1B (0%) | after a round | 560 | up | A | 0% |
| 1 Jun 2022 | $2.1B | $1.3B – $2.4B | $2.1B (0%) | after a round | 560 | up | B | 0% |
| 1 Jul 2022 | $2.1B | $1.3B – $2.4B | $2.1B (0%) | after a round | 560 | up | B | 0% |
| 1 Aug 2022 | $2.1B | $1.3B – $2.4B | $2.1B (0%) | after a round | 560 | up | B | 0% |
| 1 Sep 2022 | $2.1B | $1.3B – $2.4B | $2.1B (0%) | after a round | 560 | up | B | 0% |
| 1 Oct 2022 | $2.1B | $1.3B – $2.4B | $2.1B (0%) | after a round | 560 | up | B | 0% |
| 1 Nov 2022 | $2.1B | $1.0B – $2.4B | $2.1B (0%) | after a round | 560 | unknown | B | 0% |
| 1 Dec 2022 | $2.1B | $981M – $2.4B | $2.1B (0%) | after a round | 560 | unknown | B | 0% |
| 1 Jan 2023 | $2.1B | $1.3B – $2.4B | $2.1B (0%) | after a round | 640 | up | B | 0% |
| 1 Feb 2023 | $2.1B | $1.3B – $2.4B | $2.1B (0%) | after a round | 640 | up | B | 0% |
| 1 Mar 2023 | $2.1B | $1.3B – $2.4B | $2.1B (0%) | after a round | 640 | up | B | 0% |
| 1 Apr 2023 | $2.1B | $1.2B – $2.4B | $2.1B (0%) | after a round | 640 | up | B | 0% |
| 1 May 2023 | $2.1B | $1.2B – $2.4B | $2.1B (0%) | after a round | 640 | up | B | 0% |
| 1 Jun 2023 | $2.1B | $1.1B – $2.4B | $2.1B (0%) | after a round | 640 | up | B | 0% |
| 1 Jul 2023 | $2.1B | $1.1B – $2.4B | $2.1B (-1%) | after a round | 640 | up | B | 0% |
| 1 Aug 2023 | $2.1B | $1.1B – $2.4B | $2.1B (-1%) | after a round | 640 | up | B | 0% |
| 1 Sep 2023 | $2.1B | $1.1B – $2.4B | $2.1B (-2%) | after a round | 640 | up | B | 0% |
| 1 Oct 2023 | $2.1B | $1.0B – $2.4B | $2.1B (-2%) | after a round | 640 | up | B | 0% |
| 1 Nov 2023 | $2.1B | $578M – $2.4B | $2.0B (-5%) | after a round | 640 | flat | C | 0% |
| 1 Dec 2023 | $2.1B | $550M – $2.4B | $2.0B (-6%) | after a round | 640 | flat | C | 0% |
| 1 Jan 2024 | $2.1B | $523M – $2.4B | $2.0B (-6%) | after a round | 640 | flat | C | 0% |
| 1 Feb 2024 | $2.1B | $497M – $2.4B | $2.0B (-7%) | after a round | 640 | flat | C | 0% |
| 1 Mar 2024 | $2.1B | $478M – $2.5B | $2.0B (-7%) | after a round | 670 | flat | C | 0% |
| 1 Apr 2024 | $2.1B | $455M – $2.5B | $2.0B (-8%) | after a round | 670 | flat | C | 0% |
| 1 May 2024 | $2.1B | $433M – $2.5B | $2.0B (-8%) | after a round | 670 | flat | C | 0% |
| 1 Jun 2024 | $2.1B | $411M – $2.4B | $1.9B (-8%) | after a round | 670 | flat | C | 0% |
| 1 Jul 2024 | $2.1B | $392M – $2.4B | $1.9B (-8%) | after a round | 670 | flat | C | 0% |
| 1 Aug 2024 | $2.1B | $373M – $2.4B | $1.9B (-8%) | after a round | 680 | flat | C | 0% |
| 1 Sep 2024 | $2.1B | $355M – $2.4B | $1.9B (-8%) | after a round | 680 | flat | C | 0% |
| 1 Oct 2024 | $2.1B | $338M – $2.4B | $1.9B (-8%) | after a round | 680 | flat | C | 0% |
| 1 Nov 2024 | $2.1B | $322M – $2.4B | $1.9B (-7%) | after a round | 690 | flat | D | 0% |
| 1 Dec 2024 | $2.1B | $306M – $2.4B | $1.9B (-7%) | after a round | 690 | flat | D | 0% |
| 1 Jan 2025 | $2.0B | $291M – $2.4B | $1.9B (-7%) | after a round | 690 | flat | D | 0% |
| 1 Feb 2025 | $2.0B | $277M – $2.3B | $1.9B (-7%) | after a round | 690 | flat | D | 0% |
| 1 Mar 2025 | $2.0B | $264M – $2.3B | $1.9B (-7%) | after a round | 690 | flat | D | 0% |
| 1 Apr 2025 | $2.0B | $251M – $2.3B | $1.9B (-7%) | after a round | 690 | flat | D | 0% |
| 1 May 2025 | $2.0B | $239M – $2.3B | $1.8B (-9%) | after a round | 690 | flat | D | 0% |
| 1 Jun 2025 | $2.0B | $227M – $2.2B | $1.8B (-9%) | after a round | 690 | flat | D | 0% |
| 1 Jul 2025 | $2.0B | $218M – $2.3B | $1.8B (-8%) | after a round | 712 | flat | D | 0% |
| 1 Aug 2025 | $2.0B | $207M – $2.3B | $1.8B (-7%) | after a round | 717 | flat | D | 0% |
| 1 Sep 2025 | $2.0B | $197M – $2.3B | $1.8B (-7%) | after a round | 717 | flat | D | 0% |
| 1 Oct 2025 | $1.9B | $188M – $2.2B | $1.8B (-8%) | after a round | 717 | flat | D | 0% |
| 1 Nov 2025 | $2.0B | $180M – $2.3B | $1.8B (-7%) | after a round | 750 | flat | D | 0% |
| 1 Dec 2025 | $2.0B | $171M – $2.3B | $1.8B (-7%) | after a round | 750 | flat | D | 0% |
| 1 Jan 2026 | $1.9B | $163M – $2.2B | $1.8B (-7%) | after a round | 750 | flat | D | 0% |
| 1 Feb 2026 | $2.0B | $302M – $2.3B | $1.9B (-6%) | after a round | 773 | up | D | 0% |
| 1 Mar 2026 | $2.0B | $292M – $2.3B | $1.9B (-6%) | after a round | 773 | up | D | 0% |
| 1 Apr 2026 | $2.0B | $290M – $2.3B | $1.8B (-6%) | after a round | 773 | up | D | 0% |
| 1 May 2026 | $2.0B | $293M – $2.3B | $1.9B (-5%) | after a round | 810 | up | D | 0% |
| 1 Jun 2026 | $2.0B | $293M – $2.3B | $1.9B (-6%) | after a round | 810 | up | D | 0% |
| 1 Jul 2026 | $2.0B | $293M – $2.3B | $1.9B (-6%) | after a round | 810 | up | D | 0% |
| 1 Aug 2026 | $2.0B | $293M – $2.3B | $1.9B (-6%) | after a round | 810 | up | D | 0% |
| 1 Sep 2026 | $2.0B | $293M – $2.2B | $1.8B (-6%) | after a round | 810 | up | D | 0% |
| 1 Oct 2026 | $1.9B | $292M – $2.2B | $1.8B (-6%) | after a round | 791 | up | D | 0% |
| 24 Oct 2026 | $1.8B | $277M – $2.2B | $1.7B (-5%) | after a round | 791 | up | D | 0% |
Key facts about Collective Health
- Founded
- 2013
- Headquarters
- San Francisco, United States
- Employees
- about 791 +10% in a year
- Total raised
- $604M
- Funding rounds
- 5
- Last round
- Series F May 2021
Collective Health was founded in 2013 by Ali Diab and Rajaie Batniji.
Collective Health funding history
Collective Health has 5 funding rounds on record, from Jan 2014 to May 2021, $604M in total. The latest disclosed valuation is $1.50B post-money (Series F, May 2021).
Series F 4 May 2021
Led by Health Care Service Corporation; with SoftBank Vision Fund, DFJ Growth, Founders Fund, G Squared, Maverick Ventures, New Enterprise Associates, PFM Health Sciences, Sun Life.
Sources: collectivehealth.com, fiercehealthcare.com, 1worktech.com and 3 more
$280M
$1.50B post-money
Series E 17 Jun 2019
Led by SoftBank Vision Fund, SoftBank; with PSP Investments, DFJ Growth, G Squared, Founders Fund, GV, Maverick Ventures, Mubadala Capital, New Enterprise Associates, Sun Life.
Sources: collectivehealth.com, investpsp.com, mobihealthnews.com
$205M
Series C 20 Oct 2015
Led by GV; with Founders Fund, New Enterprise Associates, Maverick Capital, Redpoint Ventures, RRE Ventures.
Sources: collectivehealth.com, techcrunch.com, mobihealthnews.com and 3 more
$81M
Series B 18 Mar 2015
Led by New Enterprise Associates, Founders Fund; with Great Oaks Venture Capital, Formation 8. Individuals: marco demeireles, alex rodriguez, ben lin, bob young, jennifer lopez, michael stoppelman, peter hunn, scot wingo.
Sources: mg21.com
$32M
Series A 1 Jan 2014
Led by Founders Fund; with New Enterprise Associates, GV, Redpoint Ventures, RRE Ventures.
Sources: mg21.com, research.contrary.com
$6.0M
Collective Health investors
19 investors have backed Collective Health; Founders Fund, GV and New Enterprise Associates and 3 more led at least one round.
- Founders Fund lead, 5 rounds
- GV lead, 3 rounds
- New Enterprise Associates lead, 2 rounds
- SoftBank Vision Fund lead, 2 rounds
- Health Care Service Corporation lead
- SoftBank lead
- New Enterprise Associates 3 rounds
- DFJ Growth 2 rounds
- G Squared 2 rounds
- Maverick Ventures 2 rounds
- Redpoint Ventures 2 rounds
- RRE Ventures 2 rounds
- Sun Life 2 rounds
- Formation 8
- Maverick Capital
- Mubadala Capital
- PFM Health Sciences
What Collective Health does
Collective Health works in insurance - agents, carriers & brokers, with 15 recorded offerings and customers in healthcare.
Collective Health, Inc. is an American technology company that operates as a third-party administrator and health benefits platform. The company provides integrated health benefits solutions, including plan administration, claims adjudication, payments, and reporting, as well as member navigation and advocacy tools. Collective Health also offers a member app and a platform that integrates with a network of clinical partners across medical, pharmacy, dental, and vision services. The company serves employers, brokers, consultants, partners, and health systems, with a focus on self-funded employers and healthcare organizations.
Description from Veridion's company data.
Products and services
- Integrated Health Benefits Solutions
- Health Benefits Platform Development
- Medical Benefits Administration Services
- Dental Benefits Administration Services
- Vision Benefits Administration Services
- Pharmacy Benefits Administration Services
- Claims Adjudication and Payment Processing
- Health Benefits Reporting and Analytics
- Member Navigation and Advocacy Tools Development
- AI-Powered Member Navigation Solutions
- Clinical Network Access and Integration
- Health Benefits Cost Management Consulting
- Health Benefits Program Customization Services
- Employee Health Engagement Services
- Health Benefits Experience Enhancement Services
Markets
- Healthcare
Technology
- AI-Driven Member Navigation
Business model
- Business-to-Business
- Service Provider
- Software-as-a-Service
- Enterprise
Industry codes (NAICS)
- 524292 Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds 100% match
Questions about Collective Health
What is Collective Health worth?
Valuation $1.8B (range $277M to $2.2B), as of 24 Oct 2026. The last disclosed valuation was $1.50B (Series F, May 2021).
Has Collective Health raised money?
Collective Health has 5 funding rounds on record, from Jan 2014 to May 2021, $604M in total. The latest disclosed valuation is $1.50B post-money (Series F, May 2021).
Who has invested in Collective Health?
Founders Fund, GV, New Enterprise Associates, SoftBank Vision Fund, Health Care Service Corporation and SoftBank, and 13 more. Lead investors include Founders Fund, GV, New Enterprise Associates and SoftBank Vision Fund.
How many people work at Collective Health?
About 791, up 10% over the last year. Headcount grew from 440 in Jan 2021 to 791 in Sep 2026.
What does Collective Health do?
Collective Health works in insurance - agents, carriers & brokers, with 15 recorded offerings and customers in healthcare. Its main offerings are integrated health benefits solutions, health benefits platform development and medical benefits administration services.
When was Collective Health founded, and where is it based?
Collective Health was founded in 2013 and is based in San Francisco, United States. It has about 791 employees, up 10% over the last year.